SecProbe.io

Probe score transparency
Intelligence Terminal Search Topics Monthly Activity About

Probe Score Transparency

Rani Therapeutics Holdings, Inc. (RANI)
Score window: May. 30, 2025 to May. 29, 2026

Probe Score
2.5 / 10
Letters
2
Latest Activity
Aug. 12, 2025
Version
v1

Score Breakdown

Letter Count
2.0
Sentiment / Tone
0.5
Keywords
0.0
Signals
0.0
Notable 8-K Modifier
0.0
Notable 8-K Count
0

Matched Signals

No stored keyword or signal matches were recorded for this score.

Filings In This Window

DateFormSentimentUrgencySummaryOpen
Dec. 1, 2025 CORRESP Neutral/Informational Low Rani Therapeutics Holdings, Inc. has submitted a request to the SEC for their Registration Statement on Form S-3 to become effective on December 3, 2025. The company has authorize… Read Filing EDGAR
Aug. 12, 2025 CORRESP Neutral/Informational Moderate Rani Therapeutics Holdings, Inc. has submitted a request to the SEC for the acceleration of the effective date of their Registration Statement on Form S-3. The company is seeking … Read Filing EDGAR
Aug. 12, 2025 UPLOAD Neutral/Informational Low The SEC has communicated to Rani Therapeutics Holdings, Inc. that it will not review their registration statement filed on August 8, 2025. This decision indicates that the company… Read Filing EDGAR
Jul. 9, 2025 CORRESP Neutral/Informational Moderate Rani Therapeutics Holdings, Inc. has submitted a request to the U.S. Securities and Exchange Commission to expedite the effectiveness of their Registration Statement on Form S-3. … Read Filing EDGAR
Jul. 8, 2025 UPLOAD Neutral/Informational Low The SEC has informed Rani Therapeutics Holdings, Inc. that it will not review their registration statement filed on July 3, 2025. The letter emphasizes the company's responsibilit… Read Filing EDGAR

Notable 8-Ks In This Window

No notable 8-Ks were stored for this company in the score window.